Skip to Content
Merck
CN
  • MnTBAP stimulates angiogenic functions in endothelial cells through mitofusin-1.

MnTBAP stimulates angiogenic functions in endothelial cells through mitofusin-1.

Vascular pharmacology (2015-05-28)
Qian Zhou, Christoph Gensch, Constanze Keller, Hannah Schmitt, Jennifer Esser, Martin Moser, James K Liao
ABSTRACT

Angiogenesis is defined as the sprouting of capillaries from pre-existing vasculature. It is a complex process that includes endothelial proliferation, migration, and tube formation. Previous data have demonstrated a high expression level of manganese-superoxide dismutase (MnSOD) in endothelial cells and suggested an important role of MnSOD in several cardiovascular diseases. In addition, manganese (III) tetrakis (4-benzoic acid) porphyrin (MnTBAP) has been shown to mimic some of the effects of MnSOD in various tissues. However, its effect on the vasculature remains unknown. HUVECs were treated with MnTBAP. Migration, tube formation, and capillary sprouting assays were performed to evaluate the pro-angiogenic effect in vitro. Matrigel plug assay was performed to assess capillary ingrowth in vivo. Compared to control, treatment with MnTBAP revealed increased cell migration, tube formation and capillary sprouting along with more capillary ingrowth in the Matrigel plug assay. This effect was mediated through a mitofusin (Mfn)-1-dependent pathway. Expression of Tie-2, Ang-2 and VEGF mRNA was increased in muscle tissues after ligation in MnTBAP treated mice. However, revascularization in the hindlimb ischemia model was not statistically significant at day 10 in MnTBAP treated mice. In summary, our data demonstrate a strong pro-angiogenic, but less pro-arteriogenic effect of MnTBAP in HUVECs mediated by Mfn-1.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
DCFHDA, BioReagent, suitable for fluorescence, ≥95% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Mfn1
Sigma-Aldrich
MISSION® esiRNA, targeting human MFN1